Cardiac Surgery and Open-Heart Procedures
Alloksys Life Sciences B.V. focuses on clinical research in open-heart surgery, with attention to complications arising during and after cardiopulmonary bypass.
- Perioperative complications
- Post-surgical recovery
- Cardiac surgery support
The sponsor’s trial activity is centered on managing adverse events linked to the use of a heart-lung machine in surgical care.
Systemic Inflammation and Inflammatory Response
Its research interest includes systemic inflammation</span associated with cardiac surgery, particularly inflammation triggered by extracorporeal circulation.
- Inflammatory complications
- Postoperative inflammatory stress
- Critical care inflammation
Clinical work in this area reflects a focus on inflammatory instability during the immediate intensive care unit period.
Intensive Care and Organ Failure Assessment
The sponsor studies clinical outcomes in the intensive care unit, with emphasis on patient stability and severity tracking using SOFA score assessment.
- ICU stability
- Severity of illness
- Organ dysfunction monitoring
This area connects surgical recovery with close monitoring of organ function in the early postoperative setting.
Acute Kidney Injury after Cardiopulmonary Bypass
Alloksys Life Sciences B.V. also targets acute kidney injury linked to cardiopulmonary bypass, with interest in renal complications following cardiac surgery.
- Renal injury prevention
- Creatinine-based kidney assessment
- Urine output changes
Its clinical focus includes kidney protection during the postoperative period and follow-up of renal outcomes after surgery.
